Humana (HUM) 10-Q2024 Q1 Quarterly report

Filed: 24 Apr 24, 3:47pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: began, comparison, domestic, focused, forward, hierarchy, medium, overlap, retrospective, stay, uncertainty, unchanged

Removed: abandonment, abate, accelerate, area, ASU, award, centralize, chronic, Clayton, clinical, collaboration, conform, consulting, deferral, dispensing, disposed, disrupted, disruption, distinct, divestiture, Dubilier, earliest, environment, experienced, external, Finally, force, global, hospital, implement, improving, incidence, KAH, Kindred, labor, led, Louisiana, Manager, measurement, nursing, Ohio, Omicron, optimization, original, outpaced, pandemic, persist, presentation, pretax, publicly, realigned, recast, relief, Rice, seasonal, sequestration, shifting, simpler, software, structure, Supplement, Targeted, temporary, testing, traded, treatment, underway, unit, variant, work, workforce

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated HUM transcripts

HUM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Report of Humana Inc. (the "Company") on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned hereby certifies, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, in their capacity as an officer of Humana Inc., that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Bruce D. Broussard
Bruce D. Broussard Principal Executive Officer

April 24, 2024

/s/ Susan M. Diamond
Susan M. Diamond Principal Financial Officer

April 24, 2024

A signed original of this written statement required by Section 906 has been provided to Humana Inc. and will be retained by Humana Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.